MedTrace Logo

Prenatal Screening for Congenital Heart Diseases in the Antwerp Region

NCT04382222 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2020-05-18

No results posted yet for this study

Summary

No systematic research has been done in the last 15 years on the accuracy of prenatal ultrasound of congenital heart diseases in Belgium. Nor are there any population-based studies available on this subject for Belgium. Based on the data of EUROCAT (European Surveillance of Congenital Anomalies) the investigators analyse prenatal diagnostic sensitivity of congenital heart diseases in the EUROCAT regions Antwerp (Flanders, Belgium)

Conditions

  • Congenital Heart Disease in Pregnancy

Interventions

PROCEDURE

prenatal ultrasound

prenatal cardiac ultrasound

Sponsors & Collaborators

  • Universiteit Antwerpen

    lead OTHER

Principal Investigators

  • Paul Ramaekers, MD · University Antwerpen

  • Yves Jacquemyn · University Antwerpen

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2021-05-31
Completion
2021-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04382222 on ClinicalTrials.gov